Free Trial
OTCMKTS:BTCY

Biotricity (BTCY) Stock Price, News & Analysis

Biotricity logo
$0.51 +0.04 (+8.11%)
As of 06/4/2025 03:25 PM Eastern

About Biotricity Stock (OTCMKTS:BTCY)

Key Stats

Today's Range
$0.49
$0.55
50-Day Range
$0.31
$0.55
52-Week Range
$0.19
$1.09
Volume
23,117 shs
Average Volume
35,206 shs
Market Capitalization
$12.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

BTCY Stock News Headlines

H.C. Wainwright Sticks to Their Hold Rating for Biotricity (BTCY)
Biotricity expands IP portfolio with 14 new patents
Big Oil’s big pivot
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.
Biotricity reports Q3 EPS (5c) vs. (34c) last year
See More Headlines

BTCY Stock Analysis - Frequently Asked Questions

Biotricity's stock was trading at $0.2899 at the beginning of the year. Since then, BTCY stock has increased by 77.0% and is now trading at $0.5131.
View the best growth stocks for 2025 here
.

Biotricity, Inc. (OTCMKTS:BTCY) posted its quarterly earnings data on Wednesday, February, 19th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.11) by $0.06. The firm earned $3.62 million during the quarter, compared to analyst estimates of $3.30 million.
Read the conference call transcript
.

Shares of Biotricity reverse split on the morning of Monday, July 3rd 2023. The 1-6 reverse split was announced on Monday, July 3rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, July 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biotricity investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Broadcom (AVGO), Micron Technology (MU) and Bank of America (BAC).

Company Calendar

Last Earnings
2/19/2025
Today
6/05/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medical Devices
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:BTCY
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$18.66 million
Net Margins
-163.11%
Pretax Margin
-163.11%

Debt

Sales & Book Value

Annual Sales
$12.06 million
Price / Cash Flow
N/A
Book Value
($2.67) per share
Price / Book
-0.19

Miscellaneous

Free Float
6,963,000
Market Cap
$12.78 million
Optionable
Not Optionable
Beta
1.22
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:BTCY) was last updated on 6/5/2025 by MarketBeat.com Staff
From Our Partners